Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Hair loss without scarring is more common than permanent hair loss with scarring, and is often due to genetic factors.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Aging causes hair to gray and thin, with the timing of graying varying by race, and factors like oxidative stress and genetics can lead to hair loss.

Iron supplements may reverse premature graying in iron-deficient individuals; ingrown nails are common in diabetics with certain risk factors; topical finasteride may reduce scalp DHT as effectively as oral finasteride; monilethrix treatment is challenging but some medications can help.

Ageing and increased senescent cells significantly contribute to common hair loss.

AGA patients have lower serum vaspin levels, which might help detect the condition early.

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

LLLT increases hair density and growth in AGA patients.

Lower SOD enzyme levels are linked to more severe hair loss in men.

Hair loss caused by genetics and hormones; more research needed for treatments.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Lifestyle choices like stress, smoking, heavy drinking, sun exposure, and chemical hair treatments might speed up hair loss in people with androgenetic alopecia.

The treatment plan effectively improves hair growth in androgenetic alopecia.

Topical spironolactone effectively treats hair loss in women.

VEGF165 helps hair follicle stem cells become blood vessel cells, aiding new blood vessel growth.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

Women with and without hair loss have similar amounts of exogen hairs, so these hairs are not a key factor in hair loss conditions.

Targeted nanomodulators can rejuvenate cells and promote hair growth in androgenetic alopecia.

Broccoli sprout extract may help regrow hair by improving hormone metabolism.

Targeting the TNFRSF1B gene may help treat hair loss.

Plant-based treatments might help with hair loss and have fewer side effects than synthetic drugs.

Anti-angiogenic therapy can help treat cancer but may cause resistance and side effects, so alternative methods are being explored.

Hair follicle stem cells are promising for blood vessel formation and tissue repair.

Dextran hydrogels improve burn wound healing and skin regeneration.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Hospital staff have a higher rate of hair loss than the general population.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

People with early onset hair loss (Androgenetic Alopecia) in Ile-Ife, Nigeria, have significantly lower iron levels compared to those with adult-onset hair loss.